bosentan anhydrous has been researched along with Alveolitis, Fibrosing in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 12 (66.67) | 29.6817 |
| 2010's | 5 (27.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Kersh, K; Fraig, M; Perez, RL; Smith, JS | 1 |
| Barbaro Foschino, MP; Brunetti, ND; Correale, M; Di Biase, M; Lacedonia, D; Montrone, D; Totaro, A | 1 |
| Ando, K; Hoshika, Y; Ienaga, H; Kimura, T; Kuraishi, H; Morio, Y; Nagaoka, T; Takahashi, K; Tsutsumi, T | 1 |
| Antoniu, SA | 1 |
| King, TE | 1 |
| Behr, J; Brown, KK; du Bois, RM; King, TE; Leconte, I; Raghu, G; Roux, S; Swigris, J | 1 |
| Arzt, M; Blumberg, F; Nüchterlein, M; Pfeifer, M; Schroll, S; Sebah, D | 1 |
| Korn, JH | 1 |
| Clozel, M | 1 |
| Nathan, SD | 1 |
| Eickelberg, O; Günther, A; Markart, P; Seeger, W | 1 |
| Jain, M; Varga, J | 1 |
| Ewert, R; Opitz, CF | 1 |
| Ahmadi-Simab, K; Gross, WL; Hellmich, B | 1 |
| Behr, J; Enke, B; Ghofrani, HA; Grimminger, F; Günther, A; Hammerl, P; Leconte, I; Markart, P; Morr, H; Roux, S; Seeger, W; Stähler, G | 1 |
| Behr, J; Brown, KK; de Andrade, JA; du Bois, RM; King, TE; Lancaster, L; Leconte, I; Raghu, G; Roux, S; Stähler, G | 1 |
| Abraham, DJ; Black, CM; Bou-Gharios, G; Denton, CP; du Bois, RM; Kennedy, L; Leask, A; Renzoni, EA; Shi-wen, X | 1 |
| Giaid, A; Michel, RP; Park, SH; Saleh, D | 1 |
8 review(s) available for bosentan anhydrous and Alveolitis, Fibrosing
| Article | Year |
|---|---|
Novelty in treatment of pulmonary fibrosis: pulmonary hypertension drugs and others.
Topics: Antihypertensive Agents; Bosentan; Humans; Isoxazoles; Phenylpropionates; Phosphodiesterase Inhibitors; Pulmonary Fibrosis; Pyridazines; Sulfonamides; Thiophenes | 2013 |
Targeting the endothelin pathway in the idiopathic pulmonary fibrosis: the role of bosentan.
Topics: Bosentan; Endothelins; Fibrinolytic Agents; Humans; Pulmonary Fibrosis; Sulfonamides | 2008 |
Bosentan for idiopathic pulmonary fibrosis.
Topics: Animals; Bosentan; Endothelin Receptor Antagonists; Endothelin-1; Humans; Hypertension, Pulmonary; Pulmonary Fibrosis; Randomized Controlled Trials as Topic; Sulfonamides | 2008 |
Effects of bosentan on cellular processes involved in pulmonary arterial hypertension: do they explain the long-term benefit?
Topics: Animals; Antihypertensive Agents; Bosentan; Endothelium, Vascular; Humans; Hypertension, Pulmonary; Pulmonary Artery; Pulmonary Fibrosis; Sulfonamides | 2003 |
Therapeutic management of idiopathic pulmonary fibrosis: an evidence-based approach.
Topics: Acetylcysteine; Azathioprine; Benzamides; Bosentan; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Etanercept; Evidence-Based Medicine; Humans; Imatinib Mesylate; Immunoglobulin G; Interferon-gamma; Piperazines; Prednisone; Pulmonary Fibrosis; Pyridones; Pyrimidines; Receptors, Tumor Necrosis Factor; Sulfonamides | 2006 |
[Pulmonary fibrosis--a therapeutic dilemma?].
Topics: Acetylcysteine; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Benzamides; Bosentan; Cyclophosphamide; Drug Therapy, Combination; Etanercept; Free Radical Scavengers; Humans; Imatinib Mesylate; Immunoglobulin G; Immunosuppressive Agents; Interferon-gamma; Lung Transplantation; Piperazines; Protein Kinase Inhibitors; Pulmonary Fibrosis; Pyridones; Pyrimidines; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Sulfonamides | 2006 |
Bosentan for the treatment of systemic sclerosis-associated pulmonary arterial hypertension, pulmonary fibrosis and digital ulcers.
Topics: Animals; Bosentan; Drug Tolerance; Humans; Hypertension; Pulmonary Fibrosis; Scleroderma, Systemic; Skin Ulcer; Sulfonamides | 2006 |
Dual ET(A)/ET(B) vs. selective ET(A) endothelin receptor antagonism in patients with pulmonary hypertension.
Topics: Antihypertensive Agents; Bosentan; Cell Division; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin Receptor Antagonists; Endothelin-1; Humans; Hypertension, Pulmonary; Isoxazoles; Lung; Pulmonary Fibrosis; Sulfonamides; Thiophenes; Vasoconstriction; Vasodilation | 2006 |
3 trial(s) available for bosentan anhydrous and Alveolitis, Fibrosing
| Article | Year |
|---|---|
Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1).
Topics: Bosentan; Dyspnea; Humans; Pulmonary Fibrosis; Quality of Life; Sulfonamides | 2010 |
Safety and tolerability of bosentan in idiopathic pulmonary fibrosis: an open label study.
Topics: Administration, Oral; Aged; Antihypertensive Agents; Bosentan; Cardiac Catheterization; Endothelins; Female; Humans; Male; Middle Aged; Nitric Oxide; Pulmonary Fibrosis; Pulmonary Gas Exchange; Sulfonamides; Time Factors; Treatment Outcome | 2007 |
BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis.
Topics: Administration, Oral; Aged; Antihypertensive Agents; Bosentan; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Exercise Test; Female; Forced Expiratory Volume; Humans; Long-Term Care; Male; Middle Aged; Prospective Studies; Pulmonary Fibrosis; Quality of Life; Sulfonamides; Survival Rate; Tomography, Spiral Computed; Treatment Outcome; Vital Capacity | 2008 |
7 other study(ies) available for bosentan anhydrous and Alveolitis, Fibrosing
| Article | Year |
|---|---|
Smoking-related interstitial fibrosis (SRIF) and pulmonary hypertension.
Topics: Antihypertensive Agents; Biopsy; Bosentan; Carbolines; Cardiac Catheterization; Drug Therapy, Combination; Humans; Hypertension, Pulmonary; Male; Middle Aged; Pulmonary Fibrosis; Respiratory Function Tests; Smoking; Sulfonamides; Tadalafil; Tomography, X-Ray Computed; Vasodilator Agents | 2013 |
Potential Role of CT Metrics in Chronic Obstructive Pulmonary Disease with Pulmonary Hypertension.
Topics: Aged; Bosentan; Endothelin Receptor Antagonists; Exercise Test; Female; Forced Expiratory Volume; Humans; Hypertension, Pulmonary; Male; Middle Aged; Pulmonary Artery; Pulmonary Diffusing Capacity; Pulmonary Disease, Chronic Obstructive; Pulmonary Fibrosis; Sildenafil Citrate; Sulfonamides; Tadalafil; Tomography, X-Ray Computed; Vasodilator Agents; Vital Capacity | 2015 |
Improvement of bleomycin-induced pulmonary hypertension and pulmonary fibrosis by the endothelin receptor antagonist Bosentan.
Topics: Analysis of Variance; Animals; Antibiotics, Antineoplastic; Antihypertensive Agents; Bleomycin; Bosentan; Collagen; Connective Tissue Growth Factor; Disease Models, Animal; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; Male; Physical Conditioning, Animal; Pulmonary Fibrosis; Rats; Rats, Wistar; Sulfonamides; Time Factors | 2010 |
Scleroderma: a treatable disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bosentan; Humans; Pulmonary Fibrosis; Scleroderma, Systemic; Sulfonamides | 2003 |
Bosentan for severe pulmonary arterial hypertension related to systemic sclerosis with interstitial lung disease.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Bosentan; Endothelin Receptor Antagonists; Exercise Test; Female; Humans; Hypertension, Pulmonary; Lung Diseases, Interstitial; Male; Middle Aged; Prospective Studies; Pulmonary Fibrosis; Scleroderma, Systemic; Sulfonamides; Walking | 2006 |
Endothelin is a downstream mediator of profibrotic responses to transforming growth factor beta in human lung fibroblasts.
Topics: Bosentan; Cells, Cultured; Collagen Type I; Connective Tissue Growth Factor; Endothelin Receptor Antagonists; Endothelin-1; Extracellular Matrix; Fibroblasts; Fibronectins; Gene Expression Profiling; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Lung; Phenotype; Pulmonary Fibrosis; Sulfonamides; Transforming Growth Factor beta | 2007 |
Increased endothelin-1 in bleomycin-induced pulmonary fibrosis and the effect of an endothelin receptor antagonist.
Topics: Animals; Anti-Bacterial Agents; Aspartic Acid Endopeptidases; Bleomycin; Bosentan; Drug Evaluation, Preclinical; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-Converting Enzymes; Immunohistochemistry; Lung; Male; Metalloendopeptidases; Pulmonary Fibrosis; Rats; Rats, Inbred F344; Sulfonamides | 1997 |